Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results.
Saved in:
| Title: | Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results. |
|---|---|
| Authors: | Agarwal R; Richard L. Roudebush VA Medical Center and Indiana University, Indianapolis, IN, USA., Anker SD; Department of Cardiology (CVK) and Berlin Institute of Health Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin, Charité Universitätsmedizin, Berlin, Germany., Filippatos G; National and Kapodistrian University of Athens, School of Medicine, Department of Cardiology, Attikon University Hospital, Athens, Greece., Pitt B; Department of Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA., Rossing P; Steno Diabetes Center Copenhagen, Gentofte, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Ruilope LM; Cardiorenal Translational Laboratory and Hypertension Unit, Institute of Research imas12, Madrid, Spain.; CIBER-CV, Hospital Universitario 12 de Octubre, Madrid, Spain.; Faculty of Sport Sciences, European University of Madrid, Madrid, Spain., Boletis J; Faculty of Medicine, Laiko General Hospital, University of Athens, Greece., Toto R; Department of Internal Medicine, UT Southwestern, Dallas, TX, USA., Umpierrez GE; Division of Endocrinology, Metabolism, Emory University School of Medicine, Atlanta, GA, USA., Wanner C; Medizinische Klinik und Poliklinik 1, Schwerpunkt Nephrologie, Universitätsklinik Würzburg, Würzburg, Germany., Wada T; Department of Nephrology, Kanazawa University, Ishikawa, Japan., Scott C; Data Science and Analytics, Bayer PLC, Reading, UK., Joseph A; Cardiology and Nephrology Clinical Development, Bayer AG, Berlin, Germany., Ogbaa I; US Medical Affairs-Cardiovascular and Renal, Bayer U.S. LLC, Wayne, NJ, USA., Roberts L; Study Medical Experts, Bayer PLC, Reading, UK., Scheerer MF; Global Medical Affairs and Pharmacovigilance, Pharmaceuticals, Bayer AG, Berlin, Germany., Bakris GL; Department of Medicine, University of Chicago Medicine, Chicago, IL, USA. |
| Source: | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association [Nephrol Dial Transplant] 2022 Jun 23; Vol. 37 (7), pp. 1261-1269. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 8706402 Publication Model: Print Cited Medium: Internet ISSN: 1460-2385 (Electronic) Linking ISSN: 09310509 NLM ISO Abbreviation: Nephrol Dial Transplant Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1460-2385 |
|---|---|
| DOI: | 10.1093/ndt/gfab336 |
